Rheumatoid Arthritis Clinical Trials in New York

Showing 1821-1840 of 1,972 trials

Temozolomide in Treating Patients With Recurrent Malignant Glioma

NCT00004113

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who have recurrent malignant glioma.

Brain and Central Nervous System Tumors

Memorial Sloan Kettering Cancer CenterStarted Jun 1999

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

NCT00027742

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Interferon alfa may interfere with the growth of cancer cells. Combining chemotherapy with interferon alfa may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining temozolomide and interferon alfa in treating patients who have stage III or stage IV melanoma.

Intraocular MelanomaMelanoma (Skin)

Memorial Sloan Kettering Cancer CenterStarted May 2001

New York, New York, United States

COMPLETEDPhase 1< 1 mile

Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors

NCT00281944

This phase I trial is studying the side effects and best dose of oxaliplatin when given together with leucovorin and fluorouracil in treating young patients with advanced solid tumors. Drugs used in chemotherapy, such as oxaliplatin, leucovorin, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.

Childhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal TumorChildhood Central Nervous System Germ Cell Tumor+7 more

National Cancer Institute (NCI)42 participantsStarted Sep 2005

New York, New York, United States

Temozolomide in Treating Patients With Recurrent Malignant Glioma

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors

Rheumatoid Arthritis Trials in Other Cities

Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration

Egg Donor Recipient Characteristics Preferences

Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

Fecal Biomarker Study for Patients With Ulcerative Colitis

Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection

International Registry and Biorepository for TMA(Thrombotic Microangiopathy)

Investigating the Impact of Mode of Administration on Item Response

Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women

Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors

Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Clinical Efficacy Study Comparing VisionScope Imaging (VSI) to Magnetic Resonance Imaging (MRI) in Injuries of the Knee

Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).

Other Conditions in New York